Mankind Pharma, India's fourth-largest firm by market share, is selling a generic version of the drug at over one-tenth of the cost. According to the company, the cost of Empagliflozin ...

Cost of Ohtuvayre Sales (Full Year 2024): $2.6 million Research and Development Costs (Q4 2024): $7.9 million Research and Development Costs (Full Year 2024): $44.6 million Selling, General and ...